Atonco
PrivateLast Round
VC Round
Aug 1, 2025
Total Funding Raised
$6.48M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Atonco is a biotechnology company that develops innovative radiopharmaceutical therapies using alpha-emitting radionuclides, such as astatine-211, to treat cancers resistant to conventional therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atonco Comparables
Compare Atonco with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alpha Fusion Inc. | 84% | |
| Abdera Therapeutics | 82% | |
| AdvanCell | 80% | |
Atonco Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 1, 2025 | ||||
| Seed | Apr 4, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 185% MoM, from 534 to 1.5K.
- Jun 19, 2026
Monthly visitors grew 121% MoM.
Atonco Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atonco's valuation, stock price, and market status.